Budpak Hemorrhoid Anesthetic
Product Images NDC 27293-026

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Budpak Hemorrhoid Anesthetic (NDC 27293-026). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Budpak Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Package Label (Hemorrhoid Anesthetic)

Image Of Package Label (Hemorrhoid Anesthetic)
Budpak Anesthetic Ointment is an over-the-counter drug that contains active ingredients like Phenylepine HCL, Winerd ol 14%, and Peirlatum 74.9% and is intended to provide temporary relief from local anorectal burning and discomfort due to hemorthoids, inflamed hemorthoidal tissues or piles, and anorectal disorders. The ointment should not be exceeded beyond the recommended dosages, and parents of children aged below 12 years must consult a doctor before using the product. The ointment is not recommended for pregnant women without prior consultation with a doctor. In case of adverse reactions, symptoms, or worsening of the condition, users must discontinue the use and contact a doctor or poison control center. The product must be stored at room temperature, and its label indicated the lot number and expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.